A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.

Clinical Gastroenterology & Hepatology

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients

An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and challenges involving this increasingly common procedure that still remain. Dr. Kuemmerle speaks with author Dr. Alexander Khoruts.

Development of Fecal Microbiota Transplantation

An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with ventricular assist devices. Dr. Kuemmerle speaks to co-author Dr. John Vargo of the Cleveland Clinic.

Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices

A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.

Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis

An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist demonstrates value in the era of the Affordable Care Act. Dr. Kuemmerle speaks to Dr. Lawrence Kosinski.

How Gastroenterologists Can Demonstrate Value

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.

Restarting Infliximab in IBD Patients with Prior Loss of Response

An editorial in the August issue of CGH discusses changing treatment methods for Hepatitis C Virus infection over the last several years. Dr. Kuemmerle speaks to first author Dr. Fasiha Kanwal of Baylor College of Medicine.

Evolution of Hepatitis C Virus Treatment

An article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to Dr. Kathleen Corey

Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients

A commentary in the June issue of CGH looks at the effect of proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) on the lower gastrointestinal tract. Dr. Kuemmerle speaks to author Dr. Francis KL Chan.

PPIs and NSAID–Related Lower Gastrointestinal Adverse Events

A review article in the May issue of CGH looks at the major advances in risk assessment, molecular genetics, DNA mutational analyses, and cancer prevention and management of Lynch syndrome over the last 100 years; with guest Dr. Fay Kastrinos

History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome

Eosinophilic esophagitis (EoE) has become a major cause of upper gastrointestinal morbidity in children and adults. A study in the April issue of CGH estimates the prevalence of EoE in the United States. Dr. Kuemmerle speaks to author Dr. Evan S. Dellon

Prevalence of Eosinophilic Esophagitis in the U.S.

An “Advances in Translational Science” article in the March issue of CGH looks at the future of DNA testing and molecular screening for colon cancer. Dr. Kuemmerle speaks with author Dr. John M. Carethers of the University of Michigan Dept of Medicine

DNA Testing and Molecular Screening for Colon Cancer

An article in the February issue of CGH offers a primer for gastroenterologists on the use of new anticoagulant and antiplatelet agents. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes

New Anticoagulant and Antiplatelet Agents

A phase 2 study in the January 2014 issue of CGH investigated the efficacy of allogeneic mesenchymal stromal cells in patients with luminal Crohn's disease. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes

A Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

A study in the December CGH finds that constipation and a low-fiber diet are not associated with diverticulosis. A related "Perspectives in Clinical Gastroenterology and Hepatology" article reconsiders conventional wisdom about diverticular disease.

Reconsidering Diverticular Disease

An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.

hubhopper

Clinical Gastroenterology & Hepatology

hubhopper